These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
501 related articles for article (PubMed ID: 24083624)
1. Disparities in race/ethnicity and socioeconomic status: risk of mortality of breast cancer patients in the California Cancer Registry, 2000-2010. Parise CA; Caggiano V BMC Cancer; 2013 Oct; 13():449. PubMed ID: 24083624 [TBL] [Abstract][Full Text] [Related]
2. Disparities in the risk of the ER/PR/HER2 breast cancer subtypes among Asian Americans in California. Parise C; Caggiano V Cancer Epidemiol; 2014 Oct; 38(5):556-62. PubMed ID: 25172158 [TBL] [Abstract][Full Text] [Related]
3. Association of race/ethnicity, socioeconomic status, and breast cancer subtypes in the National Cancer Data Base (2010-2011). Sineshaw HM; Gaudet M; Ward EM; Flanders WD; Desantis C; Lin CC; Jemal A Breast Cancer Res Treat; 2014 Jun; 145(3):753-63. PubMed ID: 24794028 [TBL] [Abstract][Full Text] [Related]
4. Racial/Ethnic Disparities in Survival after Breast Cancer Diagnosis by Estrogen and Progesterone Receptor Status: A Pooled Analysis. John EM; McGuire V; Kurian AW; Koo J; Shariff-Marco S; Gomez SL; Cheng I; Keegan THM; Kwan ML; Bernstein L; Vigen C; Wu AH Cancer Epidemiol Biomarkers Prev; 2021 Feb; 30(2):351-363. PubMed ID: 33355191 [TBL] [Abstract][Full Text] [Related]
5. Regional Variation in Disparities in Breast Cancer Specific Mortality Due to Race/Ethnicity, Socioeconomic Status, and Urbanization. Parise CA; Caggiano V J Racial Ethn Health Disparities; 2017 Aug; 4(4):706-717. PubMed ID: 27604380 [TBL] [Abstract][Full Text] [Related]
6. HER2 status and disparities in luminal breast cancers. Holowatyj AN; Ruterbusch JJ; Ratnam M; Gorski DH; Cote ML Cancer Med; 2016 Aug; 5(8):2109-16. PubMed ID: 27250116 [TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of breast cancer subtypes and survival among Hispanic women with invasive breast cancer in California. Banegas MP; Tao L; Altekruse S; Anderson WF; John EM; Clarke CA; Gomez SL Breast Cancer Res Treat; 2014 Apr; 144(3):625-34. PubMed ID: 24658879 [TBL] [Abstract][Full Text] [Related]
8. The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: the California Cancer Registry, 1999-2004. Brown M; Tsodikov A; Bauer KR; Parise CA; Caggiano V Cancer; 2008 Feb; 112(4):737-47. PubMed ID: 18189290 [TBL] [Abstract][Full Text] [Related]
9. Impact of breast cancer subtypes on 3-year survival among adolescent and young adult women. Keegan TH; Press DJ; Tao L; DeRouen MC; Kurian AW; Clarke CA; Gomez SL Breast Cancer Res; 2013; 15(5):R95. PubMed ID: 24131591 [TBL] [Abstract][Full Text] [Related]
10. Occurrence and outcome of de novo metastatic breast cancer by subtype in a large, diverse population. Tao L; Chu L; Wang LI; Moy L; Brammer M; Song C; Green M; Kurian AW; Gomez SL; Clarke CA Cancer Causes Control; 2016 Sep; 27(9):1127-38. PubMed ID: 27496200 [TBL] [Abstract][Full Text] [Related]
11. Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status. Ma H; Lu Y; Malone KE; Marchbanks PA; Deapen DM; Spirtas R; Burkman RT; Strom BL; McDonald JA; Folger SG; Simon MS; Sullivan-Halley J; Press MF; Bernstein L BMC Cancer; 2013 May; 13():225. PubMed ID: 23642215 [TBL] [Abstract][Full Text] [Related]
12. Differences in clinicopatholgic characteristics and risk of mortality between the triple positive and ER+/PR+/HER2- breast cancer subtypes. Parise CA; Caggiano V Cancer Causes Control; 2019 May; 30(5):417-424. PubMed ID: 30879205 [TBL] [Abstract][Full Text] [Related]
13. The Influence of Socioeconomic Status on Racial/Ethnic Disparities among the ER/PR/HER2 Breast Cancer Subtypes. Parise CA; Caggiano V J Cancer Epidemiol; 2015; 2015():813456. PubMed ID: 26339244 [TBL] [Abstract][Full Text] [Related]
14. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Bauer KR; Brown M; Cress RD; Parise CA; Caggiano V Cancer; 2007 May; 109(9):1721-8. PubMed ID: 17387718 [TBL] [Abstract][Full Text] [Related]
15. Patterns of overall mortality by race/ethnicity and socioeconomic status in insured cancer patients in Southern California. Cooper RM; Chung J; Hogan T; Haque R Cancer Causes Control; 2021 Jun; 32(6):609-616. PubMed ID: 33783687 [TBL] [Abstract][Full Text] [Related]
16. Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors. Warner ET; Tamimi RM; Hughes ME; Ottesen RA; Wong YN; Edge SB; Theriault RL; Blayney DW; Niland JC; Winer EP; Weeks JC; Partridge AH J Clin Oncol; 2015 Jul; 33(20):2254-61. PubMed ID: 25964252 [TBL] [Abstract][Full Text] [Related]
17. Incidence, mortality and receptor status of breast cancer in African Caribbean women: Data from the cancer registry of Guadeloupe. Deloumeaux J; Gaumond S; Bhakkan B; Manip M'Ebobisse N; Lafrance W; Lancelot P; Vacque D; Negesse Y; Diedhiou A; Kadhel P Cancer Epidemiol; 2017 Apr; 47():42-47. PubMed ID: 28119121 [TBL] [Abstract][Full Text] [Related]
18. Breast cancer-specific survival by clinical subtype after 7 years follow-up of young and elderly women in a nationwide cohort. Johansson ALV; Trewin CB; Hjerkind KV; Ellingjord-Dale M; Johannesen TB; Ursin G Int J Cancer; 2019 Mar; 144(6):1251-1261. PubMed ID: 30367449 [TBL] [Abstract][Full Text] [Related]
19. Risk factors associated with the triple-negative breast cancer subtype within four race/ethnicities. Parise CA; Caggiano V Breast Cancer Res Treat; 2017 May; 163(1):151-158. PubMed ID: 28213780 [TBL] [Abstract][Full Text] [Related]
20. Contribution of clinical and socioeconomic factors to differences in breast cancer subtype and mortality between Hispanic and non-Hispanic white women. MartÃnez ME; Gomez SL; Tao L; Cress R; Rodriguez D; Unkart J; Schwab R; Nodora JN; Cook L; Komenaka I; Li C Breast Cancer Res Treat; 2017 Nov; 166(1):185-193. PubMed ID: 28698973 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]